(
ARTG
)
Carcinoma,Palliative treatment of recurrent and/or metastatic breast or renal cell cancer and of inoperable recurrent or metastatic endometrial carcinoma.,Endometriosis,For use in the treatment of visually proven (laparoscopy) endometriosis where the required end-point of treatment is pregnancy, or for the control of symptoms when surgery is contraindicated or has been unsuccessful.,Secondary amenorrhoea proven not due to pregnancy,In amenorrhoea associated with a poorly developed proliferative endometrium, conventional estrogen therapy may be employed in conjunction with MPA.,Abnormal uterine bleeding in the absence of organic pathology,Adjunct to estrogen therapy,Combination hormone replacement therapy, now referred to as menopausal hormone therapy (MHT), should only be used in non-hysterectomised women (see Section 4.4 Special warnings and precautions for use).
